Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per day. Less than 100 days later, the World Health Organization declared that the rapidly spreading viral outbreak had become a gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Christopher J., Harman, Robert J., Bunnell, Bruce A., Schreiber, Martin A., Xiang, Charlie, Wang, Fu-Sheng, Santidrian, Antonio F., Minev, Boris R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232924/
https://www.ncbi.nlm.nih.gov/pubmed/32423449
http://dx.doi.org/10.1186/s12967-020-02380-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232924/
https://www.ncbi.nlm.nih.gov/pubmed/32423449
http://dx.doi.org/10.1186/s12967-020-02380-2

Ejemplares similares